Institute of Pharmaceutical Biotechnology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Max-Planck-Institute for Polymer Research Mainz, Ackermannweg 10, 55128 Mainz, Germany.
Molecules. 2022 Sep 3;27(17):5693. doi: 10.3390/molecules27175693.
Recent studies have demonstrated that changes in the abundance of the intestinal bacterium , a potential probiotic, are closely associated with the development of various diseases such as obesity, diabetes, some neurodegenerative diseases, and certain cancers. However, there is still a lack of an effective method to detect the abundance of in the gut rapidly. Especially, DNA aptamers are now widely used as biometric components for medical testing due to their unique characteristics, including high chemical stability, low production cost, ease of chemical modification, low immunogenicity, and fast reproducibility. We successfully obtained a high-affinity nucleic acid aptamer library (B.p-R14) after 14 SELEX rounds, which efficiently discriminates in different analysis techniques including fluorometric suspension assays or fluorescence microscopy from other major gut bacteria in complex mixtures and even in human stool samples. These preliminary findings will be the basis towards aptamer-based biosensing applications for the fast and reliable monitoring of in the human gut microbiome.
最近的研究表明,肠道细菌丰度的变化与肥胖症、糖尿病、一些神经退行性疾病和某些癌症等各种疾病的发展密切相关。然而,目前仍然缺乏一种快速检测肠道中丰度的有效方法。特别是,由于其独特的特性,如化学稳定性高、生产成本低、易于化学修饰、免疫原性低和快速重现性,DNA 适体现在被广泛用作医学检测的生物标志物成分。经过 14 轮 SELEX 筛选,我们成功获得了一个高亲和力的核酸适体文库(B.p-R14),该文库可有效区分荧光悬浮分析或荧光显微镜等不同分析技术中的,与复杂混合物中的其他主要肠道细菌甚至人粪便样本中的进行区分。这些初步发现将为基于适体的生物传感应用提供基础,用于快速可靠地监测人类肠道微生物组中的。